HSP90AA1 and central nervous system cancer: Regardless of the limited BBB permeability of PU-H71, our results show that HSP90 inhibition with PU-H71 potently downregulates multiple pro-survival kinase pathways in glioma, overcoming inter-tumoral heterogeneity.